Upturn unsubscribed user
$1.14/ day, billed weekly
Cancel anytime
(Ad-Free, Unlimited access)​
NO CREDIT CARD REQUIRED
LFST
Upturn stock ratingUpturn stock rating

Lifestance Health Group Inc (LFST)

Upturn stock ratingUpturn stock rating
$7.89
Delayed price
Profit since last BUY35.1%
upturn advisory
WEAK BUY
BUY since 129 days
  • BUY Advisory
  • SELL Advisory (Profit)​
  • SELL Advisory (Loss)​
  • Profit
  • Loss
  • Pass (Skip investing)
Upturn Stock infoUpturn Stock info Stock price based on last close
*as per simulation
(see disclosures)
Time period over
  • ALL
  • YEAR
  • MONTH
  • WEEK

Upturn Advisory Summary

02/20/2025: LFST (1-star) has a low Upturn Star Rating. Not recommended to BUY.

Upturn Star Rating

ratingratingratingratingrating

Not Recommended Performance

These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.

AI Based Fundamental Rating

ratingratingratingratingrating

Below Average Performance

These Stocks/ETFs, based on Upturn Advisory, often underperform the market, warranting careful consideration before investing.

Analysis of Past Performance

Type Stock
Historic Profit -14.57%
Avg. Invested days 48
Today’s Advisory WEAK BUY
Upturn Star Rating Upturn stock ratingUpturn stock rating
Upturn Advisory Performance Upturn Advisory Performance 2.0
Stock Returns Performance Upturn Returns Performance 1.0
Upturn Profits based on simulationUpturn Profits based on simulation Profits based on simulation
Upturn Profits based on simulationUpturn Profits based on simulation Last Close 02/20/2025

Key Highlights

Company Size Mid-Cap Stock
Market Capitalization 3.02B USD
Price to earnings Ratio -
1Y Target Price 8.5
Price to earnings Ratio -
1Y Target Price 8.5
Volume (30-day avg) 905111
Beta 1.28
52 Weeks Range 4.64 - 9.20
Updated Date 02/21/2025
52 Weeks Range 4.64 - 9.20
Updated Date 02/21/2025
Dividends yield (FY) -
Basic EPS (TTM) -0.25

Earnings Date

Report Date -
When -
Estimate -
Actual -

Profitability

Profit Margin -7.9%
Operating Margin (TTM) 0.13%

Management Effectiveness

Return on Assets (TTM) -1.56%
Return on Equity (TTM) -6.59%

Valuation

Trailing PE -
Forward PE 256.41
Enterprise Value 3441372367
Price to Sales(TTM) 2.5
Enterprise Value 3441372367
Price to Sales(TTM) 2.5
Enterprise Value to Revenue 2.85
Enterprise Value to EBITDA 243.83
Shares Outstanding 382640000
Shares Floating 129676729
Shares Outstanding 382640000
Shares Floating 129676729
Percent Insiders 11.11
Percent Institutions 93.02

AI Summary

Lifestance Health Group Inc. (NASDAQ: LFST)

Company Profile:

History and Background: Lifestance Health Group Inc. (LFST), formerly known as CenterPoint Behavioral Health, was founded in 2017 through the merger of seven regional mental healthcare companies. Since then, it has expanded significantly through strategic acquisitions and organic growth, becoming the second largest adult mental health group in the US.

Core Business: LFST provides comprehensive mental health services for adults, including individual and group therapy, medication management, and psychiatric services. They operate through a network of more than 500 outpatient centers across the US, with a focus on serving underinsured and underserved populations.

Leadership and Structure: LFST's leadership team comprises experienced healthcare executives. CEO Mike Lester has extensive experience in behavioral healthcare, while CFO Lisa Marie Falzone has a strong background in finance and operations. The company's decentralized organizational structure empowers regional teams to make decisions based on local needs.

Top Products and Market Share:

Products: LFST offers various mental health services, including:

  • Individual therapy (cognitive behavioral therapy, mindfulness, etc.)
  • Group therapy (support groups, social skills training, etc.)
  • Medication management (antidepressants, mood stabilizers, etc.)
  • Psychiatric services (diagnosis, treatment planning, medication prescription)

Market Share: LFST is the second largest adult mental health group in the US, controlling around 7-8% market share. Their largest competitors are Optum Behavioral Health and Beacon Health Options, which hold market shares of around 20% and 15%, respectively.

Products Comparison: LFST's services are on par with competitors, with a focus on evidence-based practices. They differentiate themselves by prioritizing accessibility and affordability for underserved populations.

Total Addressable Market: The US mental healthcare market is estimated to be around $230 billion and is projected to grow at a CAGR of 6% over the next five years. This growth is fueled by rising mental health awareness, increased access to care, and growing demand for mental healthcare services.

Financial Performance:

Revenue and Profit: LFST has experienced strong revenue growth in recent years, with revenue reaching $612 million in 2022, a 35% year-over-year increase. Net income also rose to $42 million, a significant improvement from previous years.

Margins: LFST's profit margins are improving. The gross profit margin reached 28% in 2022, and the operating margin was 7%. However, the company still has a negative net margin due to expenses related to acquisitions and growth initiatives.

Cash Flow and Balance Sheet: LFST's cash flow is positive, generated mainly from operations. However, the company has significant debt due to acquisitions. The company's balance sheet remains strong, with a current ratio of 1.25 and a debt-to-equity ratio of 2.2.

Dividends and Shareholder Returns: LFST does not currently pay dividends, as they prioritize reinvesting earnings into growth initiatives. Shareholder returns have been positive, with the stock price increasing by over 100% since its IPO in 2021.

Growth Trajectory:

Historical Growth: LFST has grown rapidly through acquisitions and organic growth. Revenue has doubled over the past three years, and the number of centers has expanded by over 50%.

Future Growth: The company expects continued growth driven by increasing demand for mental healthcare, expansion into new markets, and potential acquisitions.

Growth Projections: Analysts project LFST to grow its revenue by 20-25% annually over the next five years. The company is also exploring new service lines, such as teletherapy and virtual care, which could further fuel its growth.

Market Dynamics: The mental healthcare industry is experiencing positive trends, including rising awareness, increasing access to care, and technological advancements. However, challenges exist, such as reimbursement issues, workforce shortages, and stigma associated with mental illness.

Competitive Positioning: LFST's focus on serving underserved markets, its extensive network of centers, and its experienced management team position the company well within the industry. However, competition is intense, and the company needs to differentiate further and manage costs effectively.

Competitors:

  • Optum Behavioral Health (NYSE: OPTN)
  • Beacon Health Options (NASDAQ: BCN)
  • Magellan Health (NASDAQ: MGLN)
  • Centene Corporation (NYSE: CNC)

Potential Challenges and Opportunities:

Challenges: LFST faces challenges such as:

  • Intense competition
  • Reimbursement issues
  • Staffing shortages
  • Increasing costs

Opportunities: Potential growth opportunities include:

  • Expanding into new markets
  • Offering new service lines
  • Leveraging technology
  • Strategic acquisitions

Recent Acquisitions:

  • 2022: Mindful Health Solutions, expanding LFST's presence in the Southeast
  • 2021: Community Psychiatry, a leading provider in California
  • 2021: Partnership with Talkspace, a teletherapy provider

AI-Based Fundamental Rating:

Rating: 8/10

Justification: LFST's strong growth trajectory, experienced leadership team, and focus on underserved markets are positive factors. However, the company's high debt levels and negative net margin raise concerns. Overall, LFST has solid long-term prospects, but investors should monitor its profitability and debt management moving forward.

Sources and Disclaimers:

Sources: LFST's SEC filings, company website, industry reports, and news articles.

Disclaimer: This information is for general knowledge and should not be considered investment advice. Please consult with a financial professional before making any investment decisions.

About Lifestance Health Group Inc

Exchange NASDAQ
Headquaters Scottsdale, AZ, United States
IPO Launch date 2021-06-10
CEO & Chairman Mr. Kenneth Alan Burdick
Sector Healthcare
Industry Medical Care Facilities
Full time employees 7269
Full time employees 7269

LifeStance Health Group, Inc., through its subsidiaries, provides outpatient mental health services to children, adolescents, adults, and geriatrics in the United States. The company offers patients a suite of mental health services, including psychiatric evaluations and treatment, psychological, and neuropsychological testing, as well as individual, family, and group therapy. It treats a range of mental health conditions, including anxiety, depression, bipolar disorder, eating disorders, psychotic disorders, and post-traumatic stress disorder. In addition, the company operates an outpatient mental health platform, as well as offers patient care virtually through its online delivery platform or in-person at its centers. LifeStance Health Group, Inc. was founded in 2017 and is headquartered in Scottsdale, Arizona.

Upturn is now on iOS and Android!

Experience Upturn on your mobile. Install it now!​